Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alignment Healthcare, Inc.ALHC · Entity 4269 | Chief Financial Officer | March 27, 2025 | March 28, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alignment Healthcare, Inc.
Report date March 27, 2025 · Filed March 28, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,464,419 |
Reported balance
After 2025-03-27 transaction · row 1
1 source rowRow 1 · 2025-03-27 · Sale · Disposed 6,744 · Balance 1,464,419 F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.50 to $18.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 92,929 |
Reported balance
Holding disclosure · report date 2025-03-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 92,929 F3: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
F2: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.50 to $18.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F3: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 27, 2025 Filed Mar 28, 2025 20:28 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 6,744 | $17.89 | $120,650.16 |
DisclosureSEC source: 0001628280-25-015515 · wk-form4_1743208100.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,464,419 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.50 to $18.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 19, 2025 Filed Mar 19, 2025 21:49 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,108 | $16.96 | $69,666.75 |
DisclosureSEC source: 0001628280-25-013954 · wk-form4_1742435370.xml · nonDerivative · entry 3 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,471,163 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 19, 2025 Filed Mar 19, 2025 21:49 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 7,324 | $16.09 | $117,828.51 |
DisclosureSEC source: 0001628280-25-013954 · wk-form4_1742435370.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,475,271 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 18, 2025 Filed Mar 19, 2025 21:49 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 13,815 | $16.89 | $233,343.64 |
DisclosureSEC source: 0001628280-25-013954 · wk-form4_1742435370.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,482,595 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2025 and reported on a Form 4 filed with the SEC on March 17, 2025. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.85 to $16.93. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 18:01 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 93,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-013240 · wk-form4_1742248892.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,496,410 F1 · shares: Represents (i) 61,290 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; and (ii) 32,258 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 17:01 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 208 | $15.74 | $3,273.48 |
DisclosureSEC source: 0001628280-25-012656 · wk-form4_1741899671.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,402,862 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.72 to $15.76. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 12, 2025 Filed Mar 13, 2025 17:01 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 14,484 | $15.42 | $223,388.18 |
DisclosureSEC source: 0001628280-25-012656 · wk-form4_1741899671.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,403,070 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.72 to $15.715. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 06, 2025 Filed Mar 6, 2025 19:28 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 218,295 | $15.53 | $3,390,121.35 |
DisclosureSEC source: 0001628280-25-011112 · wk-form4_1741307330.xml · nonDerivative · entry 3 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,417,554 F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs. This transaction does not represent a discretionary trade by the reporting person. F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.12 to $16.065. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 19:28 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 250,000 | $15.58 | $3,895,775.00 |
DisclosureSEC source: 0001628280-25-011112 · wk-form4_1741307330.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,635,849 F2 · kind: Date of adoption of Rule 10b5-1 plan: 11/25/2024 F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.06 to $15.86. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 19:28 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 1,020,442 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-011112 · wk-form4_1741307330.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,885,849 F1 · shares: Represents shares of common stock that were acquired upon the certification by the Compensation Committee of the Alignment Healthcare, Inc. Board of Directors of the achievement of the performance objectives under performance share units ("PSUs") granted on September 14, 2023. The PSUs were scheduled to vest only if and to the extent that certain performance objectives (health plan revenue growth percentage, at-risk returning member medical benefit ratio and adjusted EBITDA, less capital expenditures) met or exceeded specified targets. In the aggregate, the performance objectives were achieved above target. Fifty percent (50%) of the granted PSUs were fully vested on the reported date of acquisition and fifty percent (50%) will become vested on December 31, 2025, subject to the reporting person's continued service to the Company on such vesting date. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 17:16 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 30,500 | $13.42 | $409,355.75 |
DisclosureSEC source: 0001628280-24-047671 · wk-form4_1731536168.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 92,929 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/15/2024 F2 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 31, 2024 Filed Oct 31, 2024 18:11 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 36,197 | $12.04 | $435,982.01 |
DisclosureSEC source: 0001628280-24-044631 · wk-form4_1730412691.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 123,429 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/15/2024 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 29, 2024 Filed Oct 31, 2024 18:11 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,483 | $12.01 | $53,856.07 |
DisclosureSEC source: 0001628280-24-044631 · wk-form4_1730412691.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 159,626 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/15/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 17:37 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 30,500 | $11.50 | $350,872.00 |
DisclosureSEC source: 0001628280-24-042955 · wk-form4_1729114671.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 164,109 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/15/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.25 to $11.71. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 08, 2024 Filed Oct 10, 2024 18:56 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 39,320 | $12.04 | $473,349.89 |
DisclosureSEC source: 0001628280-24-042685 · wk-form4_1728600979.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 194,609 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/15/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.20. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 18:17 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 9,125 | $11.01 | $100,432.49 |
DisclosureSEC source: 0001628280-24-042224 · wk-form4_1727993843.xml · nonDerivative · entry 3 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 233,929 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.00 to $11.04. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F2 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 18:17 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 9,175 | $11.38 | $104,424.35 |
DisclosureSEC source: 0001628280-24-042224 · wk-form4_1727993843.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 243,054 F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.00 to $11.86. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F2 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 18:17 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 12,200 | $10.11 | $123,399.34 |
DisclosureSEC source: 0001628280-24-042224 · wk-form4_1727993843.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 252,229 F1 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.00 to $10.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F2 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 13, 2024 Filed Sep 13, 2024 18:19 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 14,500 | $12.00 | $174,013.05 |
DisclosureSEC source: 0001628280-24-040383 · wk-form4_1726265980.xml · nonDerivative · entry 3 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 264,429 F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/15/2024 F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.01. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 18:19 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 120,500 | $11.00 | $1,326,054.30 |
DisclosureSEC source: 0001628280-24-040383 · wk-form4_1726265980.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 278,929 F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/15/2024 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.00 to $11.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 18:19 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 8,561 | $10.01 | $85,687.91 |
DisclosureSEC source: 0001628280-24-040383 · wk-form4_1726265980.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 399,429 F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/15/2024 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.00 to $10.04. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 05, 2024 Filed Sep 6, 2024 17:28 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,789 | $10.00 | $47,912.99 |
DisclosureSEC source: 0001628280-24-039739 · wk-form4_1725658113.xml · nonDerivative · entry 3 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 407,990 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $10.00 to $10.08. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F1 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 04, 2024 Filed Sep 6, 2024 17:28 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 10 | $10.01 | $100.10 |
DisclosureSEC source: 0001628280-24-039739 · wk-form4_1725658113.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 412,779 F1 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 04, 2024 Filed Sep 6, 2024 17:28 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 1,640 | $10.00 | $16,400.00 |
DisclosureSEC source: 0001628280-24-039739 · wk-form4_1725658113.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 412,789 F1 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| July 19, 2024 Filed Jul 19, 2024 20:22 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 38,858 | $10.01 | $388,789.83 |
DisclosureSEC source: 0001628280-24-032361 · wk-form4_1721434921.xml · nonDerivative · entry 3 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 414,429 F1 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 20:22 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 44,042 | $10.00 | $440,433.21 |
DisclosureSEC source: 0001628280-24-032361 · wk-form4_1721434921.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 453,287 F1 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| July 17, 2024 Filed Jul 19, 2024 20:22 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 22,100 | $10.00 | $221,013.26 |
DisclosureSEC source: 0001628280-24-032361 · wk-form4_1721434921.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See Footnote Disclosed balance after: 497,329 F1 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| March 28, 2024 Filed Mar 29, 2024 20:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,299 | $4.84 | $20,807.16 |
DisclosureSEC source: 0001209191-24-005137 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 865,407 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.73 to $4.935. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 19, 2024 Filed Mar 21, 2024 17:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 28,522 | $5.05 | $144,058.92 |
DisclosureSEC source: 0001209191-24-005034 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 869,706 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2024 and reported on a Form 4 filed with the SEC on March 15, 2024. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.48 to $5.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 20:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 11,858 | $4.89 | $57,998.66 |
DisclosureSEC source: 0001209191-24-004871 · doc4.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 898,228 F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $4.77 to $5.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 200,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004871 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 910,086 F1 · shares: Represents (i) 110,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; (ii) 21,000 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors; and (iii) 69,710 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2023 fiscal year. Read SEC document |
| March 31, 2023 Filed Mar 31, 2023 17:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 3,290 | $6.26 | $20,608.23 |
DisclosureSEC source: 0001209191-23-021894 · doc4.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 709,376 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock. This transaction does not represent a discretionary trade by the reporting person. F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.211 to $6.33. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 29, 2023 Filed Mar 31, 2023 17:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 5,312 | $6.11 | $32,473.85 |
DisclosureSEC source: 0001209191-23-021894 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 712,666 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $6.02 to $6.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 14, 2023 Filed Mar 15, 2023 18:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 13,470 | $6.33 | $85,224.69 |
DisclosureSEC source: 0001209191-23-018988 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 717,978 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $5.93 to $6.74. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 18:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 1,100 | $13.01 | $14,308.03 |
DisclosureSEC source: 0001209191-23-004323 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 519,429 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.05. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| December 01, 2022 Filed Dec 2, 2022 19:26 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 24,000 | $13.10 | $314,445.60 |
DisclosureSEC source: 0001209191-22-059509 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 520,529 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.41. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 16:27 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 24,000 | $13.23 | $317,611.20 |
DisclosureSEC source: 0001209191-22-055290 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 544,529 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.10 to $13.38. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 16:25 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 24,000 | $13.08 | $313,828.80 |
DisclosureSEC source: 0001209191-22-054806 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 568,529 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.00 to $13.25. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| September 12, 2022 Filed Sep 13, 2022 18:32 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 319,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-049767 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 731,448 F1 · kind: Represents 319,179 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 50% on each of the third and fourth anniversaries of the grant date, subject to the reporting person's continued service to the Company. Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 16:10 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 24,000 | $14.56 | $349,363.20 |
DisclosureSEC source: 0001209191-22-048482 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 592,529 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.30 to $14.82. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 16:32 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 2,913 | $19.01 | $55,363.90 |
DisclosureSEC source: 0001209191-22-045008 · doc4.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 616,529 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.00 to $19.06. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 16:32 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 40,497 | $18.51 | $749,761.46 |
DisclosureSEC source: 0001209191-22-045008 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 619,442 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.00 to $18.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (4) to this Form 4. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 21:21 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 24,000 | $14.50 | $348,019.20 |
DisclosureSEC source: 0001209191-22-044010 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 659,939 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 18:51 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 20,383 | $12.48 | $254,404.30 |
DisclosureSEC source: 0001209191-22-041516 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 683,939 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.88. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 19:04 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 12,000 | $11.40 | $136,838.40 |
DisclosureSEC source: 0001209191-22-040365 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 704,322 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.00 to $11.51. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| June 22, 2022 Filed Jun 23, 2022 16:46 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 100 | $12.00 | $1,200.00 |
DisclosureSEC source: 0001209191-22-038918 · doc4.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 716,322 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| June 21, 2022 Filed Jun 23, 2022 16:46 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 3,517 | $12.01 | $42,249.02 |
DisclosureSEC source: 0001209191-22-038918 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 716,422 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $12.00 to $12.06. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| June 17, 2022 Filed Jun 17, 2022 17:55 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 12,000 | $11.18 | $134,114.40 |
DisclosureSEC source: 0001209191-22-038017 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 719,939 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $11.03 to $11.35. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. F3 · ownership.nature: Represents securities held by FCO Holdings LLC, a limited liability company owned by FCO Holdings Trust One, an irrevocable trust of which Mr. Freeman is an indirect beneficiary. Read SEC document |
| April 01, 2022 Filed Apr 1, 2022 19:14 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 3,292 | $11.42 | $37,582.13 |
DisclosureSEC source: 0001209191-22-022083 · doc4.xml · nonDerivative · entry 2 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,269 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares sold on March 31, 2022 were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. Shares sold on April 1, 2022 were sold in multiple transactions at a per share price ranging from $11.31 to $11.61. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 19:14 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,944 | $11.18 | $55,252.66 |
DisclosureSEC source: 0001209191-22-022083 · doc4.xml · nonDerivative · entry 1 Freeman Robert Thomas · CIK 0001850414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,561 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares sold on March 31, 2022 were sold in multiple transactions at a per share price ranging from $10.73 to $11.45. Shares sold on April 1, 2022 were sold in multiple transactions at a per share price ranging from $11.31 to $11.61. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.